JOMPAC

Journal of Medicine and Palliative Care (JOMPAC) is an open access scientific journal with independent, unbiased, and double-blind review under international guidelines. The purpose of JOMPAC is to contribute to the literature by publishing articles on health sciences and medicine.

EndNote Style
Index
Original Article
Non dipping pattern frequency and metabolic syndrome relationship according to two different metabolic syndrome diagnostic methods in newly diagnosed hypertensive individuals
Aim: The literature presents conflicting data regarding whether the non dipping pattern (NDP) in patients with metabolic syndrome (MS) compared to those without. In our study, we aimed to investigate the MS effect of the NDP in individuals with hypertension. Methods: This prospective study included 117 newly diagnosed hypertensive patients (79 women and 38 men) who were not receiving any anti-hypertensive treatment. MS was evaluated according to the currently used the US National Cholesterol Education Programme Adult Treatment Panel-III definition criteria (MS-ATP-III) and a new diagnostic scoring method (MS-Score). NDP defined, nocturnal blood pressure (BP) fell by <10% from daytime BP Results: The mean age of the patients who met the MS-ATP-III criteria was 53.9+8.1 years. The prevalence of the MS-ATP-III among the study population was 60.6%. The NDP frequency was similar in patients with and without MS-ATP-III, high MS-Score and low MS-Score group (respectively; 44.8%, 47.5%, p=0.79, 44.7%, 46.9%, p= 0.9). The reverse dipping pattern (RDP) frequency was higher in patients with MS-ATP-III compared to those without MS (13.8% and 2.5%, p=0.021), RDP was 10.8% in the high MS-Score group and 8.2% in the low MS-Score group (p=0.66). The LDL (mg/dL) values were higher in those with NDP compared to those without (142.6+32.2, 125.5+28.9, p=0.008). Conclusion: Despite the high prevalence of MS among newly diagnosed hypertensive patients, the prevalence of NDP does not show a different distribution in patients with MS in both the MS-ATP-III and MS-Score method.


1. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The NationalCholesterol Education Program - Adult Treatment PanelIII, International Diabetes Federation, and World HealthOrganization definitions of the metabolic syndrome as predictorsof incident cardiovascular disease and diabetes. Diabetes Care.2007;30(1):8-13. doi:10.2337/dc06-1414
2. Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidityand mortality associated with the metabolic syndrome. DiabetesCare. 2001;24(4):683-689. doi:10.2337/diacare.24.4.683
3. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein,the metabolic syndrome, and risk of incident cardiovascularevents: an 8-year follow-up of 14 719 initially healthy Americanwomen. Circulation. 2003;107(3):391-397. doi:10.1161/01.cir.0000055014.62083.05
4. Schillaci G, Pirro M, Vaudo G, et al. Prognostic value of themetabolic syndrome in essential hypertension. J Am Coll Cardiol.2004;43(10):1817-1822. doi:10.1016/j.jacc.2003.12.049
5. Cuspidi C, Meani S, Fusi V, et al. Metabolic syndrome and targetorgan damage in untreated essential hypertensives. J Hypertens.2004;22(10):1991-1998. doi:10.1097/00004872-200410000-00023
6. Preda A, Liberale L, Montecucco F. Imaging techniques forthe assessment of adverse cardiac remodeling in metabolicsyndrome. Heart Fail Rev. 2022;27(5):1883-1897. doi:10.1007/s10741-021-10195-6
7. Saadi MM, Roy MN, Haque R, Tania FA, Mahmood S, Ali N.Association of microalbuminuria with metabolic syndrome:a cross-sectional study in Bangladesh. BMC Endocr Disord.2020;20(1):153. doi:10.1186/s12902-020-00634-0
8. Schillaci G, Pirro M, Pucci G, et al. Different impact of themetabolic syndrome on left ventricular structure and functionin hypertensive men and women. Hypertension. 2006;47(5):881-886. doi:10.1161/01.HYP.0000216778.83626.39
9. O&#39;Brien E, Sheridan J, O&#39;Malley K. Dippers and non-dippers.Lancet. 1988;2(8607):397. doi:10.1016/s0140-6736(88)92867-x
10. Chobanian AC, Bakris GL, Black HR, et al. National Heart, Lung,and Blood Institue Joint National Committe on Prevention,Detection, Evaluation, and Treatment of High Blood Pressure;National Hİgh Blood Pressure Education Program CoordinationCommittee The JNC 7 Report. JAMA. 2003;289:2560-2572.
11. Chia J, Bhatia KS, Mihailidou AS, Kanagaratnam LB. The roleof ambulatory blood pressure monitoring in current clinicalpractice. Heart Lung Circ. 2022;31(10):1333-1340. doi:10.1016/j.hlc.2022.06.670
12. Pickering TG, Shimbo D, Haas D. Ambulatory blood-pressuremonitoring. N Engl J Med. 2006;354(22):2368-2374. doi:10.1056/NEJMra060433
13. Kohara K, Nishida W, Maguchi M, Hiwada K. Autonomicnervous function in non-dipper essential hypertensive subjects.Evaluation by power spectral analysis of heart rate variability.Hypertension. 1995;26(5):808-814. doi:10.1161/01.hyp.26.5.808
14. Lind L, Andersson PE, Andr&eacute;n B, H&auml;nni A, Lithell HO. Leftventricular hypertrophy in hypertension is associated withthe insulin resistance metabolic syndrome. J Hypertens.1995;13(4):433-438.
15. De Pergola G, Ciccone M, Pannacciulli N, et al. Lower insulinsensitivity as an independent risk factor for carotid wallthickening in normotensive, non-diabetic, non-smokingnormal weight and obese premenopausal women. Int JObes Relat Metab Disord. 2000;24(7):825-829. doi:10.1038/sj.ijo.0801239
16. Brotman DJ, Davidson MB, Boumitri M, Vidt DG. Impaireddiurnal blood pressure variation and all-cause mortality. Am JHypertens. 2008;21(1):92-97. doi:10.1038/ajh.2007.7
17. Dolan E, Stanton A, Thijs L, et al. Superiority of ambulatory overclinic blood pressure measurement in predicting mortality:the Dublin outcome study. Hypertension. 2005;46(1):156-161.doi:10.1161/01.HYP.0000170138.56903.7a
18. Ayala DE, Hermida RC, Chayan L, Moj&oacute;n A, Fontao MJ,Fern&aacute;ndez JR. Circadian pattern of ambulatory bloodpressure in untreated hypertensive patients with and withoutmetabolic syndrome. Chronobiol Int. 2009;26(6):1189-1205.doi:10.3109/07420520903206294
19. Mul&egrave; G, Nardi E, Cottone S, et al. Relationship of metabolicsyndrome with pulse pressure in patients with essentialhypertension. Am J Hypertens. 2007;20(2):197-203. doi:10.1016/j.amjhyper.2006.07.016
20. Vyssoulis GP, Karpanou EA, Kyvelou SM, et al. Nocturnal bloodpressure fall and metabolic syndrome score in hypertensivepatients. Blood Pressure Monitoring. 2007;12(6):351-356. DOI:10.1097/mbp.0b013e3282cb5ad3. PMID: 18004102.
21. Tartan Z, Uyarel H, Kasikcioglu H, et al. Metabolic syndromeas a predictor of non-dipping hypertension. Tohoku J Exp Med.2006;210(1):57-66. doi:10.1620/tjem.210.57
22. Cuspidi C, Meani S, Valerio C, et al. Metabolic syndromescore and ambulatory blood pressure in untreated essentialhypertension. Blood Press Monit. 2005;10(4):175-180.doi:10.1097 /01.mbp.0000170921.55412.02
23. Bastos JM, Bertoquini S, Pol&oacute;nia J. Relationship of circadianblood pressure and morning blood pressure surge withthe severity of metabolic syndrome in newly diagnosedhypertensives. Rev Port Cardiol. 2007;26(7-8):731-741.
24. Foss CH, Vestbo E, Fr&oslash;land A, Gjessing HJ, Mogensen CE,Damsgaard EM. Normal blood pressure and preserved diurnalvariation in offspring of type 2 diabetic patients characterizedby features of the metabolic syndrome: the FredericiaStudy. Diabetes Care. 2000;23(3):283-289. doi:10.2337/diacare.23.3.283
25. Mancia G, Bombelli M, Corrao G, et al. Metabolic syndromein the Pressioni Arteriose Monitorate E Loro Associazioni(PAMELA) study: daily life blood pressure, cardiacdamage, and prognosis. Hypertension. 2007;49(1):40-47.doi:10.1161/01.HYP.0000251933.22091.24
26. Expert Panel on Detection, Evaluation, and Treatment ofHigh Blood Cholesterol in Adults. Executive Summary ofThe Third Report of The National Cholesterol EducationProgram (NCEP) Expert Panel on Detection, Evaluation,And Treatment of High Blood Cholesterol In Adults (AdultTreatment Panel III). JAMA. 2001;285(19):2486-2497.doi:10.1001/jama.285.19.2486
27. Ford ES, Schulze MB, Pischon T, Bergmann MM, Joost HG,Boeing H. Metabolic syndrome and risk of incident diabetes:findings from the European Prospective Investigation intoCancer and Nutrition-Potsdam Study. Cardiovasc Diabetol.2008;7:35. Published 2008 Dec 12. doi:10.1186/1475-2840-7-35
28. Mancia G, De Backer G, Dominiczak A, et al. 2007 Guidelinesfor the Management of Arterial Hypertension: The Task Forcefor the Management of Arterial Hypertension of the EuropeanSociety of Hypertension (ESH) and of the European Societyof Cardiology (ESC). J Hypertens. 2007;25(6):1105-1187.doi:10.1097/HJH.0b013e3281fc975a
29. Dickstein K, Cohen-Solal A, Filippatos G, et al. ESC Guidelinesfor the diagnosis and treatment of acute and chronic heart failure2008: the Task Force for the Diagnosis and Treatment of Acuteand Chronic Heart Failure 2008 of the European Society ofCardiology. Developed in collaboration with the Heart FailureAssociation of the ESC (HFA) and endorsed by the EuropeanSociety of Intensive Care Medicine (ESICM). Eur Heart J.2008;29(19):2388-2442. doi:10.1093/eurheartj/ehn309
30. Benetos A, Safar M, Rudnichi A, et al. Pulse pressure: a predictorof long-term cardiovascular mortality in a French malepopulation. Hypertension. 1997;30(6):1410-1415. doi:10.1161/01.hyp.30.6.1410
31. Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not meanpressure determines cardiovascular risk in older hypertensivepatients. Arch Intern Med. 2000;160(8):1085-1089. doi:10.1001/archinte.160.8.1085
32. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulsepressure useful in predicting risk for coronary heart Disease?The Framingham heart study. Circulation. 1999;100(4):354-360.doi:10.1161/01.cir.100.4.354
33. Yan B, Yan H, Sun L, et al. Novel association betweenthe reverse-dipper pattern of ambulatory blood pressuremonitoring and metabolic syndrome in men but not inwomen. Medicine (Baltimore). 2015;94(47):e2115. doi:10.1097/MD.0000000000002115
34. Yan B, Peng L, Dong Q, et al. Reverse-dipper pattern of bloodpressure may predict lacunar infarction in patients with essentialhypertension. Eur J Neurol. 2015;22(6):1022-1025. doi:10.1111/ene.12659
35. Chen YK, Ni ZX, Li W, et al. Diurnal blood pressureand heart rate variability in hypertensive patients withcerebral small vessel disease: a case-control study. JStroke Cerebrovasc Dis. 2021;30(5):105673. doi:10.1016/j.jstrokecerebrovasdis.2021.105673
36. Kim BK, Kim YM, Lee Y, Lim YH, Shin J. A reverse dippingpattern predicts cardiovascular mortality in a clinical cohort.J Korean Med Sci. 2013;28(10):1468-1473. doi:10.3346/jkms.2013.28.10.1468
37. Cuspidi C, Tadic M, Sala C, Carugo S, Mancia G, Grassi G. Reversedipping and subclinical cardiac organ damage: a meta-analysis ofechocardiographic studies. J Hypertens. 2021;39(8):1505-1512.doi:10.1097/HJH.0000000000002836
Volume 4, Issue 4, 2023
Page : 373-379
_Footer